RKDA
Arcadia Biosciences, Inc. (NASDAQ)
Consumer Defensive — Packaged Foods
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
None
$0.75
+$0.07 (+10.31%)
Sign in to add RKDA to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $1.54M |
| P/E Ratio (TTM) | - |
| Forward P/E | -0.59 |
| EPS (TTM) | $-5.72 |
| Dividend Yield | - |
| Profit Margin | -195.94% |
| Revenue Growth | -8.30% |
| ROE | -158.15% |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 39.4 |
| Beta | 0.50 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $6.71 |
| 52-Week Low | $0.63 |
| 50-Day Avg | $0.96 |
| 200-Day Avg | $2.31 |
| Avg Volume | $3.13M |
| Volume | 154.2K |
Performance Analysis
BEARISHRKDA is flashing more cautionary signals — investors should monitor closely.
+
Trading near its 52-week low ($0.63), which could present a value opportunity.
~
RSI at 39.4 is in neutral territory.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
-
Revenue declined 8.3% year-over-year.
-
Operating at a loss with -195.9% margin.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 02, 2026 13:29 UTC
Back to Screener Export Report